Abstract
Pyruvic acid is an organic acid found in most biological systems as an end product of the metabolism of sugar or starch and its carboxalate anion is known as pyruvate. Pyruvate enters in the Krebs cycle to generate the ATP. It is an effective scavenger of reactive oxygen species (ROS) and OH-. It also inhibits tumor necrosis factor-a production, iNOS (inducible nitric oxide synthase), and IL-6 (interleukin-6) levels. Pyruvates have instability in solution, inorder to avoid this problem different analogs of pyruvate were developed. Treatment with ethyl pyruvate like pyruvate esters has been shown to be effective in a wide variety of preclinical models. In this review, reported pharmacological actions of pyruvate analogues like anti inflammatory, antioxidants, anticancer, neuroprotective etc are discussed.
Keywords: Anti-inflammatory, antioxidant, ethyl pyruvate, pyruvate, sodium pyruvate, reactive oxygen species, metabolism of sugar, neuroprotective, anticancer, hydrogen peroxide
Current Drug Therapy
Title:“The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Volume: 7 Issue: 2
Author(s): Niraj S. Vyawahare, Varsha J. Bansode and Neeraj B. Munjal
Affiliation:
Keywords: Anti-inflammatory, antioxidant, ethyl pyruvate, pyruvate, sodium pyruvate, reactive oxygen species, metabolism of sugar, neuroprotective, anticancer, hydrogen peroxide
Abstract: Pyruvic acid is an organic acid found in most biological systems as an end product of the metabolism of sugar or starch and its carboxalate anion is known as pyruvate. Pyruvate enters in the Krebs cycle to generate the ATP. It is an effective scavenger of reactive oxygen species (ROS) and OH-. It also inhibits tumor necrosis factor-a production, iNOS (inducible nitric oxide synthase), and IL-6 (interleukin-6) levels. Pyruvates have instability in solution, inorder to avoid this problem different analogs of pyruvate were developed. Treatment with ethyl pyruvate like pyruvate esters has been shown to be effective in a wide variety of preclinical models. In this review, reported pharmacological actions of pyruvate analogues like anti inflammatory, antioxidants, anticancer, neuroprotective etc are discussed.
Export Options
About this article
Cite this article as:
S. Vyawahare Niraj, J. Bansode Varsha and B. Munjal Neeraj, “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives, Current Drug Therapy 2012; 7 (2) . https://dx.doi.org/10.2174/157488512800676048
DOI https://dx.doi.org/10.2174/157488512800676048 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oleic Acid in Olive Oil: From a Metabolic Framework Toward a Clinical Perspective
Current Pharmaceutical Design Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Mini-Reviews in Medicinal Chemistry Soluble CD40L and its Role in Essential Hypertension: Diagnostic and Therapeutic Implications
Cardiovascular & Hematological Disorders-Drug Targets The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews Early Vascular Aging: A New Target for Hypertension Treatment
Current Pharmaceutical Design Xanthine Oxidase Inhibitors the Unappreciated Treatment for Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Current Respiratory Medicine Reviews Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research Production and Purification of Functional Lipids Through Enzymatic and Microorganism-Mediated Processes
Current Organic Chemistry Adeno-associated Viral Vectors for Correction of Inborn Errors of Metabolism: Progressing Towards Clinical Application
Current Pharmaceutical Design Carotenoids of Microalgae Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry A Comparative Assessment of Metabolic Syndrome and its Association with Vitamin D and Other Risk Factors in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?
Current Hypertension Reviews Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
Current Alzheimer Research New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Animal Models of Atherosclerosis Progression: Current Concepts
Current Drug Targets - Cardiovascular & Hematological Disorders Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Current Drug Targets Psoriasis vulgaris and Psoriasis pustulosa – Epidemiology, Quality of Life, Comorbidities and Treatment
Current Rheumatology Reviews Nutrigenetics, Metabolic Syndrome Risk and Personalized Nutrition
Current Vascular Pharmacology Ibubrofen in the Treatment of Patent Ductus Arteriosus in Preterm Infants: What We Know, What We Still Do Not Know
Current Pharmaceutical Design